Persisting fatigue in Hodgkin lymphoma survivors: a systematic review

LA Daniëls, S Oerlemans, ADG Krol… - Annals of …, 2013 - Springer
Hodgkin Lymphoma (HL) survivors are at risk for adverse psychosocial events as a result
from cancer diagnosis and treatment. Fatigue is one of the most frequently reported long …

Long-term cause-specific mortality in Hodgkin lymphoma patients

S de Vries, M Schaapveld, CPM Janus… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Few studies have examined the impact of treatment-related morbidity on long-
term, cause-specific mortality in Hodgkin lymphoma (HL) patients. Methods This multicenter …

Cancer-related fatigue in relation to chronotype and sleep quality in (non-) Hodgkin lymphoma survivors

DEJ Starreveld, GEA Habers… - Journal of biological …, 2021 - journals.sagepub.com
Cancer-related fatigue has been related to circadian disruptions and lower levels of sleep
quality. However, it is unknown whether the circadian phase, which is associated with …

Different manifestation of irradiation induced coronary artery disease detected with coronary computed tomography compared with matched non-irradiated controls

AR van Rosendael, LA Daniëls… - Radiotherapy and …, 2017 - Elsevier
Background and purpose Patients who received chest irradiation for treatment of a
malignancy are at increased risk for the development of coronary artery atherosclerosis …

Recommendations for the optimal radiation dose in patients with primary cutaneous anaplastic large cell lymphoma: a report of the Dutch Cutaneous Lymphoma …

RC Melchers, R Willemze, LA Daniëls, KJ Neelis… - International Journal of …, 2017 - Elsevier
Purpose To determine the optimal radiation dose for treatment of primary cutaneous
anaplastic large cell lymphoma (C-ALCL) with solitary or localized, multifocal or recurrent …

Long-term risk of secondary skin cancers after radiation therapy for Hodgkin's lymphoma

LA Daniëls, ADG Krol, M Schaapveld, H Putter… - Radiotherapy and …, 2013 - Elsevier
Abstract Purpose Survivors of Hodgkin's lymphoma (HL) are at risk of secondary tumors. We
investigated the risk of secondary skin cancers after radiotherapy compared to treatment …

[HTML][HTML] High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors

S De Vries, M Schaapveld, FA Van Nimwegen… - British journal of …, 2018 - nature.com
Background: Hodgkin lymphoma (HL) patients are at an increased risk of late adverse
treatment effects. While published studies focussed on the risk of either subsequent …

Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease

RC Melchers, R Willemze, JSP Vermaat… - Blood, The Journal …, 2020 - ashpublications.org
Conflict-of-interest disclosure: IG received travel and research funding from Bristol-Myers
Squibb (BMS). IR received honorarium, travel, and research funding from BMS; and …

Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivors

LA Daniëls, SDG Krol, MA de Graaf… - International Journal of …, 2014 - Elsevier
Purpose Cardiovascular disease (CVD) is the most common nonmalignant cause of death in
Hodgkin lymphoma (HL) survivors, especially after mediastinal irradiation. The role of …

Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA)

IM Krul, AWJ Opstal-van Winden, JM Zijlstra… - BMJ open, 2018 - bmjopen.bmj.com
Introduction Hodgkin's lymphoma (HL) has become the prototype of a curable disease.
However, many young survivors suffer from late adverse effects of treatment. Both …